Xeris Biopharma Holdings, Inc.
XERS
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 291.8 | 291.8 | 203.1 | 110.2 | 110.2 | 49.6 | 20.2 | 2.5 | 1.6 | 1.1 | |
| Cost of Revenues | 53.4 | 53.4 | 36.8 | 22.6 | 22.6 | 13.3 | 9.3 | 0.0 | 0.0 | 0.0 | |
| Gross Profit | 238.4 | 238.4 | 166.2 | 87.6 | 87.6 | 36.3 | 10.8 | 2.4 | 1.6 | 1.1 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 85.8 | 74.4 | 71.5 | 60.1 | 60.1 | 54.3 | 48.1 | 40.6 | 38.0 | 33.2 | |
| Cost of Revenues | 19.1 | 11.0 | 14.6 | 8.7 | 9.5 | 13.6 | 10.5 | 6.0 | 7.6 | 5.3 | |
| Gross Profit | 66.7 | 63.4 | 56.9 | 51.4 | 50.6 | 40.7 | 37.6 | 34.7 | 30.5 | 27.9 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 21.0 | 21.0 | 25.2 | 20.9 | 40.7 | 20.2 | 10.2 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 137.7 | 137.7 | 125.7 | 73.7 | 21.1 | 8.0 | 4.1 | |
| Depreciation & Amortization | 12.5 | 12.2 | 12.6 | 12.7 | 10.8 | 0.6 | 3.0 | 0.3 | 0.2 | 0.1 | |
| Total Operating Expenses | 213.5 | 213.5 | 199.9 | 169.6 | 169.6 | 151.4 | 94.4 | 61.8 | 28.2 | 14.3 | |
| Operating Income | 24.9 | 24.9 | -33.6 | -81.9 | -81.9 | -115.2 | -83.5 | -59.3 | -26.6 | -13.2 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 6.1 | 4.8 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 37.6 | 33.6 | ||
| Depreciation & Amortization | 3.0 | 3.2 | 3.2 | 3.1 | 3.1 | 3.1 | 3.2 | 3.2 | 3.4 | 3.2 | ||
| Total Operating Expenses | 50.0 | 56.7 | 52.4 | 54.5 | 48.9 | 53.6 | 45.8 | 48.9 | 46.4 | 41.2 | ||
| Operating Income | 16.8 | 6.7 | 4.5 | -3.1 | 1.7 | -12.9 | -8.2 | -14.2 | -16.0 | -13.3 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 4.7 | 4.7 | 5.3 | 2.6 | 2.6 | 0.3 | 3.0 | 1.6 | 0.1 | 0.0 | |
| Interest Expense | 29.1 | 29.1 | 33.2 | 15.3 | 15.3 | 7.2 | 10.7 | 2.5 | 0.0 | 0.0 | |
| Other Expense | -24.3 | -24.3 | -23.5 | -14.1 | -14.1 | -7.6 | -7.7 | 0.2 | 0.0 | 0.0 | |
| IBT | 0.6 | 0.6 | -57.1 | -96.1 | -96.1 | -122.7 | -91.3 | -60.1 | -26.6 | -13.2 | |
| Income Tax Expense | 0.0 | 0.0 | -2.3 | -1.4 | -1.4 | -0.1 | -0.1 | 1.8 | 0.0 | 0.0 | |
| Net Income | 0.6 | 0.6 | -54.8 | -94.7 | -94.7 | -122.7 | -91.1 | -60.1 | -26.6 | -13.2 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 1.5 | 1.2 | 0.9 | 1.2 | 0.9 | 1.2 | 1.3 | 1.9 | 1.2 | 1.3 | ||
| Interest Expense | 7.2 | 7.3 | 7.4 | 7.3 | 7.7 | 7.8 | 8.0 | 7.0 | 6.5 | 6.2 | ||
| Other Expense | -5.7 | -6.1 | -6.4 | -6.1 | -6.8 | -6.2 | -6.1 | -4.4 | -4.5 | -3.6 | ||
| IBT | 11.1 | 0.6 | -1.9 | -9.2 | -5.1 | -19.1 | -14.3 | -18.7 | -20.5 | -16.8 | ||
| Income Tax Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -3.3 | 0.7 | 0.3 | -0.7 | 2.8 | ||
| Net Income | 11.1 | 0.6 | -1.9 | -9.2 | -5.1 | -15.7 | -15.0 | -19.0 | -19.8 | -16.8 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-0.70 | $-0.70 | $-1.55 | $-2.14 | $-4.99 | $-12.24 | $-6.09 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-0.70 | $-0.70 | $-1.55 | $-2.14 | $-4.99 | $-12.24 | $-6.09 | |
| Shares Outstanding | 166.0 | 160.4 | 146.8 | 135.6 | 135.6 | 79.0 | 42.6 | 12.0 | 2.2 | 2.2 | |
| Diluted Shares Outstanding | 180.1 | 172.7 | 146.8 | 135.6 | 135.6 | 79.0 | 42.6 | 12.0 | 2.2 | 2.2 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.14 | $-0.12 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.14 | $-0.12 | ||
| Shares Outstanding | 166.0 | 177.6 | 156.0 | 152.4 | 149.1 | 149.0 | 148.3 | 140.5 | 137.3 | 137.1 | ||
| Diluted Shares Outstanding | 180.1 | 177.6 | 156.0 | 152.4 | 149.1 | 149.0 | 148.3 | 140.5 | 137.3 | 137.1 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 57.6 | 71.6 | 122.0 | 122.0 | 67.3 | 37.6 | 45.7 | 42.0 | 32.3 | |
| Short Term Investments | 20.0 | 0.0 | 0.0 | 35.2 | 35.2 | 96.2 | 66.9 | 0.0 | 0.0 | |
| Total Cash & ST Investments | 77.6 | 71.6 | 122.0 | 122.0 | 102.4 | 133.8 | 112.6 | 42.0 | 32.3 | |
| Accounts Receivable | 42.4 | 40.4 | 30.8 | 30.8 | 17.5 | 6.9 | 2.9 | 1.2 | 0.1 | |
| Inventory | 43.0 | 48.2 | 24.7 | 24.7 | 18.1 | 8.4 | 0.0 | 0.0 | 0.0 | |
| Other Current Assets | 7.4 | 7.5 | 9.3 | 9.3 | 4.6 | 3.2 | 2.4 | 0.8 | 0.8 | |
| Total Current Assets | 170.3 | 167.7 | 186.8 | 186.8 | 142.6 | 152.2 | 117.9 | 44.1 | 33.2 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 91.6 | 59.3 | 58.4 | 71.6 | 59.2 | 57.6 | 62.7 | 46.2 | 51.0 | 46.2 | |
| Short Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 10.2 | 20.0 | 24.7 | 34.5 | 44.1 | 34.5 | |
| Total Cash & ST Investments | 91.6 | 59.3 | 58.4 | 71.6 | 69.4 | 77.6 | 87.4 | 80.7 | 95.1 | 80.7 | |
| Accounts Receivable | 53.8 | 53.0 | 46.3 | 40.4 | 41.1 | 42.4 | 37.4 | 30.2 | 30.9 | 30.8 | |
| Inventory | 67.5 | 67.3 | 52.7 | 48.2 | 45.1 | 43.0 | 40.9 | 36.5 | 29.0 | 36.5 | |
| Other Current Assets | 11.2 | 6.0 | 6.0 | 7.5 | 7.1 | 7.4 | 7.6 | 8.3 | 10.5 | 9.3 | |
| Total Current Assets | 224.0 | 185.6 | 163.5 | 167.7 | 162.8 | 170.3 | 173.3 | 155.7 | 165.5 | 155.7 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 28.7 | 28.2 | 28.4 | 28.4 | 6.6 | 6.7 | 2.0 | 0.8 | 0.3 | |
| Goodwill | 22.9 | 22.9 | 120.6 | 120.6 | 22.9 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 104.3 | 98.9 | 4.0 | 4.0 | 131.5 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 4.2 | 4.1 | 4.3 | 0.0 | 0.0 | 13.2 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 1.3 | -4.8 | 0.3 | 4.7 | 0.8 | -13.0 | 0.1 | 0.2 | 0.0 | |
| Total Long-Term Assets | 161.4 | 155.4 | 157.7 | 157.7 | 161.8 | 6.9 | 2.1 | 0.9 | 0.4 | |
| Total Assets | 331.7 | 323.1 | 344.5 | 344.5 | 304.4 | 159.2 | 120.0 | 45.0 | 33.5 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 27.2 | 27.7 | 27.8 | 28.2 | 28.4 | 28.7 | 28.8 | 30.2 | 10.4 | 30.2 | |
| Goodwill | 22.9 | 22.9 | 22.9 | 22.9 | 22.9 | 22.9 | 22.9 | 22.9 | 22.9 | 22.9 | |
| Intangible Assets | 90.8 | 93.5 | 96.2 | 98.9 | 101.6 | 104.3 | 107.1 | 115.2 | 117.9 | 115.2 | |
| Long-Term Investments | 0.0 | 0.0 | 4.1 | 4.1 | 0.0 | 4.2 | 0.0 | 0.0 | 4.3 | 4.3 | |
| Other Long-Term Assets | 5.3 | 5.1 | 1.0 | 1.3 | 5.4 | 1.3 | 4.6 | 4.8 | 4.7 | 0.3 | |
| Total Long-Term Assets | 146.2 | 149.1 | 152.0 | 155.4 | 158.3 | 161.4 | 163.3 | 173.0 | 155.8 | 173.0 | |
| Total Assets | 370.2 | 334.7 | 315.5 | 323.1 | 321.1 | 331.7 | 336.6 | 328.8 | 321.4 | 328.8 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 5.8 | 2.3 | 4.6 | 4.6 | 8.9 | 3.1 | 0.9 | 2.0 | 1.3 | |
| Short-Term Debt | 5.3 | 21.2 | 3.2 | 1.6 | 0.0 | 0.0 | 8.2 | 2.6 | 0.9 | |
| Other Current Liabilities | 64.4 | 77.0 | 65.9 | 67.4 | 70.1 | 25.1 | 0.9 | 0.1 | 0.0 | |
| Current Liabilities | 75.5 | 100.4 | 73.6 | 73.6 | 79.0 | 28.2 | 10.2 | 4.9 | 2.5 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 6.5 | 9.5 | 6.4 | 2.3 | 7.5 | 5.8 | 7.1 | 11.6 | 12.0 | 4.6 | |
| Short-Term Debt | 6.2 | 6.2 | 18.1 | 21.2 | 21.1 | 5.3 | 4.6 | 3.9 | 2.9 | 1.6 | |
| Other Current Liabilities | 103.5 | 79.6 | 70.6 | 77.0 | 62.5 | 64.4 | 61.4 | 64.2 | 66.5 | 67.4 | |
| Current Liabilities | 116.2 | 95.2 | 95.1 | 100.4 | 91.0 | 75.5 | 73.1 | 79.7 | 81.4 | 79.7 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 230.5 | 250.3 | 196.5 | 196.5 | 88.1 | 87.0 | 31.9 | 0.0 | 0.0 | |
| Capital Leases | 34.0 | 39.3 | 11.0 | 11.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | 3.3 | 0.0 | 3.5 | 3.5 | 4.9 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 351.0 | 352.7 | 299.3 | 299.3 | 209.1 | 125.4 | 44.6 | 102.8 | 65.5 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 32.0 | 251.1 | 250.7 | 250.3 | 249.9 | 264.5 | 264.1 | 223.1 | 197.0 | 196.5 | |
| Capital Leases | 38.2 | 38.6 | 39.0 | 39.3 | 39.7 | 34.0 | 39.0 | 36.8 | 10.8 | 36.8 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 3.3 | 2.6 | 2.8 | 3.5 | 2.8 | |
| Total Liabilities | 371.1 | 354.0 | 350.6 | 352.7 | 349.4 | 351.0 | 345.8 | 315.1 | 291.3 | 315.1 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -651.0 | -671.9 | -554.8 | -554.8 | -460.1 | -337.4 | -120.7 | -60.6 | -34.0 | |
| Comprehensive Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | -0.4 | -0.3 | |
| Total Common Equity | -19.3 | -29.6 | 45.2 | 45.2 | 95.2 | 33.8 | 75.4 | -57.8 | -31.9 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -682.4 | -683.0 | -681.1 | -671.9 | -666.7 | -651.0 | -636.0 | -591.4 | -571.6 | -591.4 | |
| Comprehensive Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | 0.0 | -0.1 | |
| Total Common Equity | -0.9 | -19.3 | -35.1 | -29.6 | -28.3 | -19.3 | -9.2 | 13.6 | 30.0 | 13.6 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 269.8 | 271.4 | 198.1 | 198.1 | 88.1 | 87.0 | 31.9 | 0.0 | 0.0 | |
| Book Value | -19.3 | -29.6 | 45.2 | 45.2 | 95.2 | 33.8 | 75.4 | -57.8 | -31.9 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | -0.9 | -19.3 | -35.1 | -29.6 | -28.3 | -19.3 | -9.2 | 13.6 | 30.0 | 13.6 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -59.6 | 0.6 | -54.8 | -94.7 | -94.7 | -122.7 | -91.1 | -60.1 | -26.6 | -13.2 | |
| Depreciation & Amortization | 13.0 | 12.2 | 12.6 | 12.7 | 12.7 | 1.9 | 1.5 | 0.3 | 0.2 | 0.1 | |
| Stock-Based Compensation | 13.2 | 22.4 | 18.4 | 12.2 | 12.2 | 11.4 | 8.3 | 1.7 | 0.5 | 0.5 | |
| Change Working Capital | -1.9 | -10.4 | -8.8 | -35.2 | -35.2 | 11.9 | -2.8 | 1.6 | 1.1 | -3.6 | |
| Change In Accounts Receivable | -12.2 | -10.6 | -1.2 | -13.4 | -13.4 | -6.2 | -2.2 | -1.7 | -1.1 | 0.2 | |
| Change In Accounts Payable | -6.1 | -0.1 | -9.6 | -4.3 | -4.3 | 5.5 | -2.5 | -1.1 | 0.7 | -2.9 | |
| Change In Inventories | -8.2 | -19.3 | -8.8 | -7.5 | -7.5 | -7.4 | -5.1 | 4.0 | 1.7 | -0.8 | |
| Other Non-cash Items | 28.3 | 3.9 | -2.0 | 3.5 | 3.5 | 1.0 | 3.1 | 0.6 | 0.1 | 0.0 | |
| Cash from Operations | -39.0 | 0.0 | 0.0 | -102.9 | -102.9 | -95.5 | -80.6 | -56.3 | -24.7 | -16.1 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 11.1 | 0.6 | -1.9 | -9.2 | -5.1 | -15.7 | -15.0 | -19.0 | -19.8 | -16.8 | |
| Depreciation & Amortization | 3.0 | 3.0 | 2.9 | 3.1 | 3.1 | 2.7 | 3.2 | 3.2 | 3.4 | 3.2 | |
| Stock-Based Compensation | 5.3 | 7.6 | 5.0 | 4.4 | 3.6 | 6.8 | 4.2 | 3.8 | 2.9 | 2.6 | |
| Change Working Capital | -0.4 | 6.1 | -6.9 | -9.2 | -0.5 | 9.0 | -3.4 | -5.6 | 0.4 | -13.9 | |
| Change In Accounts Receivable | 2.7 | -0.7 | -6.7 | -5.9 | 0.7 | 1.3 | -5.0 | 1.8 | 0.6 | 0.0 | |
| Change In Accounts Payable | -1.7 | 2.0 | -4.4 | 4.1 | -5.2 | 1.7 | -1.6 | -4.5 | 0.1 | 6.9 | |
| Change In Inventories | -4.0 | -4.1 | -7.6 | -3.6 | -3.1 | -1.0 | -2.3 | -2.3 | -7.4 | -3.8 | |
| Other Non-cash Items | 1.0 | 1.0 | 1.1 | 0.8 | 0.8 | -7.7 | -0.1 | -3.0 | -0.2 | -0.8 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -13.7 | -26.1 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -1.0 | -0.7 | -0.9 | -0.5 | -0.5 | -1.1 | -0.4 | -1.5 | -0.7 | 0.0 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 38.5 | 38.5 | 0.4 | 0.0 | 0.0 | 0.0 | |
| Investments | -29.5 | 0.0 | -34.5 | 0.0 | -43.0 | -43.0 | -101.8 | -68.9 | 0.0 | 0.0 | |
| Sales of Investment | 45.0 | 0.0 | 40.2 | 35.0 | 35.0 | 103.6 | 74.7 | 2.1 | 0.0 | 0.0 | |
| Other Investing Activities | 10.5 | 0.0 | 0.0 | 35.0 | 4.6 | 0.0 | -0.4 | 0.0 | 0.0 | 0.0 | |
| Cash from Investing | 14.5 | 0.0 | 0.0 | 34.5 | 34.5 | 98.0 | -27.4 | -68.3 | -0.7 | 0.0 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -0.3 | -0.4 | 0.0 | 0.0 | -0.2 | -0.1 | -0.4 | -0.2 | -1.5 | -0.2 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -5.0 | -5.0 | -24.5 | 0.0 | -43.7 | |
| Sales of Investment | 0.0 | 0.0 | 0.0 | 0.0 | 10.2 | 15.0 | 10.0 | 5.0 | 10.0 | 0.0 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 10.0 | -43.7 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 8.5 | -44.0 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -38.2 | 0.0 | 0.0 | 102.7 | -43.5 | -25.1 | -25.1 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 83.0 | 271.4 | 73.4 | 300.8 | 153.5 | 26.1 | 80.2 | 31.9 | 0.0 | 0.0 | |
| Issuance of Common Stock | 1.1 | 0.0 | 0.0 | 30.0 | 30.0 | 27.0 | 65.9 | 98.3 | 0.0 | 0.0 | |
| Repurchase of Common Stock | -3.6 | -10.9 | -3.7 | -0.5 | -0.5 | -0.5 | -0.1 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -25.1 | -95.6 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | -12.6 | 0.0 | 0.0 | -4.8 | 141.4 | 51.0 | 181.0 | 29.9 | 35.1 | 3.9 | |
| Cash from Financing | 35.7 | 0.0 | 0.0 | 127.5 | 127.5 | 27.2 | 126.1 | 128.2 | 35.1 | 3.9 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 38.2 | -219.0 | -11.5 | -2.7 | 0.5 | 1.2 | 1.1 | 43.7 | 26.6 | -26.6 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Repurchase of Common Stock | -1.5 | -0.5 | 8.0 | -8.0 | -0.2 | -0.1 | -0.1 | -3.4 | 0.0 | -0.9 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.6 | 0.0 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.6 | -0.9 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 11.4 | 39.3 | 4.1 | 59.0 | 59.0 | 29.7 | 18.1 | 3.7 | 9.8 | -12.2 | |
| Closing Cash Balance | 57.6 | 115.1 | 75.7 | 126.3 | 126.3 | 67.3 | 37.6 | 45.7 | 42.0 | 32.3 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 19.4 | 32.2 | 0.8 | -13.2 | 12.4 | 1.5 | -5.1 | -4.8 | -4.7 | -71.0 | |
| Closing Cash Balance | 115.1 | 95.6 | 59.3 | 62.6 | 75.7 | 63.4 | 57.6 | 62.7 | 50.6 | 55.3 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -40.0 | 27.9 | -37.8 | -103.4 | -103.4 | -96.6 | -80.9 | -57.8 | -25.4 | -16.1 | |
| Real Free Cash Flow | -53.2 | 5.6 | -56.2 | -115.6 | -115.6 | -108.0 | -89.2 | -59.5 | -25.9 | -16.7 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 19.7 | 18.1 | 10.0 | -10.0 | 1.8 | -8.4 | -10.7 | -20.5 | -15.3 | -26.4 | |
| Real Free Cash Flow | 14.4 | 10.4 | 5.0 | -14.5 | -1.8 | -15.2 | -15.0 | -24.2 | -18.2 | -28.9 |
